Open AccessHigh Frequency of Tc22 and Th22 Cells in Myasthenia Gravis Patients and Their Significant Reduction after Thymectomy
Author(s) -
Behrouz Robat-Jazi,
Mina Hosseini,
Vahid Shaygannejad,
Shahriar Nafissi,
Abbas Rezaei,
Marjan Mansourain,
Omid Mirmosayyeb,
Nafiseh Esmaeil
Publication year - 2018
Publication title -
neuroimmunomodulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.635
H-Index - 65
eISSN - 1423-0216
pISSN - 1021-7401
DOI - 10.1159/000490855
Subject(s) - myasthenia gravis , thymectomy , pathogenesis , medicine , gastroenterology , autoimmune disease , disease , endocrinology
Myasthenia gravis (MG) is an autoimmune disease accompanied by a thymic pathology and in most patients thymectomy (TE) is used as the therapeutic approach. Both B and T cells play an important role in MG pathogenesis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom